Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04066283 · ClinicalTrials.gov registry record
Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 29
- Enrollment target
NCT04066283: Completed study, sponsored by University of Colorado, Denver.
NCT04066283 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04066283 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This study will examine markers of vascular endothelial function (vascular health) and metabolic profiles in younger versus older transgender women (people who were assigned male at birth but whose gender identity is female). Data will also be compared to those from cisgender women and men.
Primary Outcome
Brachial artery flow-mediated dilation (FMD), as measured by ultrasound.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2019-04-17 |
| Est. Completion | 2023-12-31 |
What the finished NCT04066283 record still lists
NCT04066283 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04066283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04066283 about?
NCT04066283 is a clinical study titled "Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women". This study will examine markers of vascular endothelial function (vascular health) and metabolic profiles in younger versus older transgender women (people who were assigned male at birth but whose gender identity is female). Data will also be compared to those from cisgender women and men.
What is the current status of trial NCT04066283?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2019-04-17. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04066283?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04066283?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI